Neurotransmitter Actions and Interactions | Proceedings of a Satellite Symposium of the 12th International Society for Neurochemistry Meeting, Algarve, Portugal, April 29–30, 1989 | ISBN 9783709190500
Theodore Lionel Sourkes : an appreciation.- Reflections at seventy.- The psychopharmacology of GABA synapses : update 1989.- Formation of 12-lipoxy-genase metabolites in rat cerebral cortical slices: stimulation by calcium iono-phore, glutamate and N-methyl-D-aspartate.- Role of excitatory amino acid neurotransmission in synaptic plasticity and pathology. An integrative hypothesis concerning the pathogenesis and evolutionary advantages of schizophrenia-related genes.- Neurochemical approaches to the amelioration of brain injury.- Neuronal nicotinic ?-bungarotoxin receptors.- Involvement of neuropeptide Y in neuroendocrine stress responses. Central and peripheral studies.- Peptide regulation of adrenal medullary function.- Inborn errors of carnosine and homocarnosine metabolism.- Histamine inactivation in the brain: aspects of N-methylation.- Phenylethylamine in the CNS: effects of monoamine oxidase inhibiting drugs, deuterium substitution and lesions and its role in the neuromodulation of catecholaminergic neurotransmission.- Biological model for the in vivo measurement of rate of serotonin synthesis in the brain.- Cerebral serotonin in viral encephalitis.- Retinal neurotransmitter interaction as reflected in horizontal cell spatial behaviour.- Phenolsulfotransferase (PST) and PAPS in catecholamine metabolism in human tissues: an overview.- Effect of some peptides on dopaminergic function in man.- Respective contributions of neuronal activity and presynaptic mechanisms in the control of the in vivo release of dopamine.- Investigations on auto-antibodies in Alzheimer’s and Parkinson’s diseases, using defined neuronal cultures.- Implantable microencapsulated dopamine (DA): prolonged functional release of DA in denervated striatal tissue.- Partial damage tonigrostriatal bundle : compensatory changes and the action of L-DOPA.- MAO and L-DOPA treatment of Parkinson’s disease.- Oxidative stress: a role in the pathogenesis of Parkinson’s disease.- Selectivity of melaninized nigro-striatal dopamine neurons to degeneration in Parkinson’s disease may depend on ironmelanin interaction.- The effects of aging on MAO activity and amino acid levels in rat brain.- The interactions of monoamine oxidase with some derivatives of l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP).- From moclobemide to Ro 19-6327 and Ro 41-1049: the development of a new class of reversible, selective MAO-A and MAO-B inhibitors.
